Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
H2BFXP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPATA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLURP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507425 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK5RAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1I - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAMP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPINT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEK9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC38A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on